Nemaura Medical Inc.
Company Snapshot: Nemaura Medical Inc.
NMRD | ||||
Last | Change | Volume | High | Low |
Company Overview

Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes specialty medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. The company was founded in 2009 and is headquartered in Loughborough, the United Kingdom.
Client News
- Jan 27 2023 Nemaura Medical Announces Pricing of Approximately $8.4 Million Registered Direct Offering and Concurrent Private Placement
- Jan 26 2023 Nemaura Medical Receives First Purchase Order from U.S. Health Provider HealthFleet
- Jan 24 2023 Nemaura Medical Reports Initial Patient Data from UK NHS Miboko Study that Demonstrates Weight Loss in 100% of Participants
- Jan 11 2023 Nemaura Medical to Present at the Sidoti & Co. Micro Cap Virtual Conference